“When you consider they lost 11% of their earnings in the [fiscal] third quarter, Walgreens has taken a significant hit [as a result of its spat with Express Scripts]. Their credibility, I think, is compromised, and certainly their position in the market overall has been compromised by this. So I would expect them to take a fairly aggressive approach to trying to recover, and the question is whether they’re going to be able to.”
— Brian Bullock, R. Ph., founder and CEO of the pharmacy benefit consultancy The Burchfield Group, told AIS’s Drug Benefit News
No comments:
Post a Comment